Citations

Mayo Clinic

Showing 10 of 108523 citations.

Bringing Geroscience into the Mainstream: From Education to Clinical Practice, What Will It Take?
Al‐Naggar, Iman M. , Justice, Jamie N. , Orr, Miranda E. , Kozikowski, Chester, Willik, Odette van der, Thatcher, Christine, Schmader, Kenneth E. , Pignolo, Robert J. , Newman, John C. , Justice, Jamie N , Newman, John C , Campellone, Kenneth G. , Espinoza, Sara , Kuchel, George A.

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences | August 10, 2024 | Volume: 79 | Issue: 9 | Pages: No page available

10.1093/gerona/glae020 | PMID 39126344 Get It

A Pragmatic Approach to Introducing Translational Geroscience Into the Clinic: A Paradigm Based on the Incremental Progression of Aging-Related Clinical Research
Forman, Daniel E. , Pignolo, Robert J. , Forman, Daniel Edward

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences | August 10, 2024 | Volume: 79 | Issue: 9 | Pages: No page available

10.1093/gerona/glae062 | PMID 39126296 Get It

Abstract Geroscience posits that molecular drivers underlie the aging process. Gerotherapeutics entail strategies to counter molecular drivers of aging to reduce the chronic diseases and geriatric syndromes they trigger. Although the concept of gerotherapeutics for prevention has generated much excitement, the implications of prescribing potentially harmful medications to older adults who are “healthy” have been associated with many delays. Concerns regarding safety and valid endpoints have contributed to holdups. In contrast, it has been relatively easier to implement trials of medications with gerotherapeutic properties as novel approaches to remedy disease. In these applications, the risks of the medications are easier to justify when therapeutic benefits are perceived as outweighing the harms of the disease. Likewise, metrics of effective disease treatments are often seen as more reliable and quantifiable than metrics of health prolongation. Overall, clarifying geroscience mechanisms in disease therapeutic applications provides key opportunities to advance translational geroscience, especially as preventive geroscience trials are often encumbered. In this review, gerotherapeutic benefits of canakinumab, cholchicine, and zoledronic acid as parts of disease management are considered. Longevity Clinics and other opportunities to advance translational geroscience as parts of contemporary care are also discussed.
Nonpelvic comorbid symptoms of 45 patients with pain of pelvic venous origin, before and after treatment
Smith, Steven J. , Sichlau, Michael J. , Chen, Brenda, Knight, Dacre , Rowe, Peter C. , Smith, B Holly , Knight, Dacre R T , Rowe, Peter C

Phlebology: The Journal of Venous Disease | August 10, 2024 | Volume: 40 | Issue: 2 | Pages: 66-79

10.1177/02683555241273109 | PMID 39126670 Get It

Objective To report the prevalence and severity of nonpelvic symptoms for patients with venous-origin chronic pelvic pain (VO-CPP) and to describe outcomes after pelvic vein stenting and embolization. Methods We retrospectively reviewed outcomes of 45 women with VO-CPP who underwent treatment with iliac vein stenting and/or embolization. Patients completed symptom-severity questionnaires before and after treatment that assessed for pelvic pain, and multiple other symptoms, including brain fog, anxiety, depression, musculoskeletal pain, fatigue, migraines and more. Results Patient age ranged from 18 to 65 years. The prevalence of common symptoms was as follows: migraines, 69%; brain fog, 76%; anxiety attacks, 58%; excess sweating, 64%; hip pain, 73%; diarrhea, 62%; constipation, 76%; and abdominal bloating, 82%. After treatment, most symptom scores improved by more than 50%; exceptions were excessive sweating (41% improvement) and bloating (47% improvement). Prevalence of individual symptoms that bundle into POTS ranged from 29% to 76%, where symptom improvement ranged from 23% to 59% after treatment. Overlapping individual symptoms characteristic of fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) were present in 64% to 82% of patients and all improved by 49% to 63% after treatment. Conclusions Pelvic venous flow abnormality is linked causally to a spectrum of interrelated symptoms, of which many can be bundled into named syndromes of unknown cause. With catheter- based treatment of pelvic venous pooling, nonpelvic symptom and syndrome scores improved.
Immune Effector Cell-Associated Enterocolitis following Chimeric Antigen Receptor T-cell Therapy in Multiple Myeloma
Song, Jinming , Lekakis, Lazaros J. , Samraj, Annie N. , Naresh, Kikkeri N. , Vazquez‐Martinez, Mariola , Mikkilineni, Lekha , Corraes, Andre De Menezes Silva , Kalariya, Nilesh, Patel, Krina K. , Ferreri, Christopher J. , Voorhees, Peter M. , Valdes, Cesar Rodriguez , Cowan, Andrew J., Sborov, Douglas W. , Lin, Yi, Naresh, Kikkeri N , Fortuna, Gliceida Galarza , Banerjee, Rahul , Fernandez‐Pol, Sebastian , Baz, Rachid , Spiegel, Jay Y. , Gubatan, John , Sidana, Surbhi , Shim, Kevin G. , Fonseca, Rafaël , Richard, Shambavi , Hansen, Doris K. , Wang, Yinghong

No container title available | August 10, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4727434/v1 Get It

Abstract Background: Several immune effector cell (IEC) therapies have been approved for multiple myeloma (MM), including chimeric antigen receptor T-cell (CAR-T) therapies such as idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel). We report 14 cases of IEC-associated enterocolitis, in five cases fatal, following CAR-T therapy in MM. Methods: We performed a retrospective analysis of cases of diarrhea, enterocolitis, or colitis following commercial ide-cel or cilta-cel (including out-of-specification products) at 10 centers within the United States Myeloma Immunotherapy Consortium. Patients were treated according to the local standard of care at each participating center. Results: We identified 14 cases of IEC-associated enterocolitis out of 1159 CAR-T infusions, corresponding to a 1.2% incidence (0.2% for ide-cel and 2.3% for cilta-cel). This proportion excludes 3 cases of potential or confirmed T-cell lymphoproliferative disorders of the bowel. Patients developed acute-onset symptoms (typically non-bloody Grade 3+ diarrhea) with negative infectious workup beginning a median of 79 days (range: 22-210 days) after CAR-T therapy and a median of 74 days after cytokine release syndrome resolution (range: 2-202 days). Biopsies uniformly demonstrated inflammation, with specific findings including intra-epithelial lymphocytosis, crypt dropout on colon biopsies, and villous blunting on duodenal biopsies. Systemic corticosteroids were initiated in 10 patients (71%) a median of 26 days (range: 1-80 days) following symptom onset. Only 40% of steroid-treated patients had symptomatic improvement; subsequent infliximab or vedolizumab led to improvement in 50% and 33% of corticosteroid-refractory patients, respectively. With a median follow-up of 224 days, n = 4 have had diarrhea resolution, n = 5 have had improved or stable symptoms, and n = 5 (36%) have died from IEC-associated enterocolitis or treatment-emergent infections. Conclusions: IEC-associated enterocolitis is a distinct but rare complication of CAR-T therapy characterized by non-bloody diarrhea typically beginning 1-3 months after infusion. Thorough diagnostic workup (including evaluation for potential T-cell malignancies) and appropriate management with an expert gastroenterologist are essential. Further research is critical to understand the pathogenesis of this novel toxicity. In the interim, the early use of infliximab or vedolizumab may potentially hasten symptom resolution and lower reliance on high-dose corticosteroids during the post-CAR-T period.
Comparison of human observer impression of X-ray fluoroscopy and angiography image quality with technical changes to image quality
Miller, Daniel L. , Bell, Malcolm R. , Fetterly, Kenneth A. , Mihailovic, Jelena M , Miller, Daniel , Mihailović, Jelena M. , Kanaji, Yoshihisa

Journal of Medical Imaging | August 10, 2024 | Volume: 11 | Issue: 04 | Pages: No page available

10.1117/1.jmi.11.4.045502 | PMID 39131567 Get It

Scalable information extraction from free text electronic health records using large language models
Gu, Bowen , Shao, Vivian, Liao, Ziqian , Carducci, Valentina , Desai, Rishi , Romero‐Brufau, Santiago , Yang, Jie

No container title available | August 10, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4714451/v1 Get It

Abstract Background A vast amount of potentially useful information such as description of patient symptoms, family, and social history is recorded as free-text notes in electronic health records (EHRs) but is difficult to reliably extract at scale, limiting their utility in research. This study aims to assess whether an “out of the box” implementation of open-source large language models (LLMs) without any fine-tuning can accurately extract social determinants of health (SDoH) data from free-text clinical notes. Methods We conducted a cross-sectional study using EHR data from the Mass General Brigham (MGB) system, analyzing free-text notes for SDoH information. We selected a random sample of 200 patients and manually labeled nine SDoH aspects. Eight advanced open-source LLMs were evaluated against a baseline pattern-matching model. Two human reviewers provided the manual labels, achieving 93% inter-annotator agreement. LLM performance was assessed using accuracy metrics for overall, mentioned, and non-mentioned SDoH, and macro F1 scores. Results LLMs outperformed the baseline pattern-matching approach, particularly for explicitly mentioned SDoH, achieving up to 40% higher Accuracymentioned. openchat_3.5 was the best-performing model, surpassing the baseline in overall accuracy across all nine SDoH aspects. The refined pipeline with prompt engineering reduced hallucinations and improved accuracy. Conclusions Open-source LLMs are effective and scalable tools for extracting SDoH from unstructured EHRs, surpassing traditional pattern-matching methods. Further refinement and domain-specific training could enhance their utility in clinical research and predictive analytics, improving healthcare outcomes and addressing health disparities.
Pneumonitis in older lung cancer patients after radiotherapy (POLCAR): A prospective study to develop a scoring instrument that helps identify radiation pneumonitis in elderly patients with lung cancer
Rades, Dirk , Zwaan, Inga, Ohlen, Daphne Schepers-von, Bohnet, Sabine , Timke, Carmen , Duma, Marciana Nona , Keerl, Silke, Bartscht, Tobias , Yu, Nathan Y. , Werner, Elisa, Janssen, Stefan , Kristiansen, Charlotte

No container title available | August 10, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4716583/v1 Get It

Abstract Background: Pneumonitis caused by radiotherapy for lung cancer may be missed, since it often occurs only several months later. In a previous trial including patients of any age, a symptom-based scoring system was tested to facilitate the correct diagnosis of radiation pneumonitis. Since elderly lung cancer patients have a greater risk of developing this complication, a separate scoring system particularly for this age group appears reasonable. This trial investigates such a specific tool for elderly patients irradiated for lung cancer. Methods: Patients with lung cancer patients aged ≥65 years will be included in this prospective multi-center trial and complete paper-based questionnaires (symptom-based scoring system). Patients indicate and rate symptoms potentially caused by pneumonitis, namely cough, dyspnea, and fever, once a week during and up to 24 weeks following their radiotherapy course. If symptomatic (grade ≥2) pneumonitis is confirmed by corresponding diagnostic procedures, patients receive prednisolone whenever possible. The total score of the symptom-based scoring system, which ranges between 0 and 9 points, is correlated to pneumonitis (yes or no). The discriminative power of the scoring system is evaluated by calculating the area under the receiver operating characteristic curve (AUC). Optimality is defined as a cut-off score with sensitivity ≥90% and specificity ≥80%. In addition, the Youden index (sensitivity + specificity – 1) will be applied. Fifty-nine patients (18 with and 41 without pneumonitis) are required in the full analysis set. Assuming that 5% of the patients will not qualify for this set, 62 patients should be enrolled. In addition, patient satisfaction with the scoring system is evaluated. If the dissatisfaction rate is >20%, the score needs modifications; if the dissatisfaction rate is >40%, the scoring system is considered not useful. Discussion: If the optimal cut-off score facilitates the diagnosis of radiation pneumonitis and its discrimination from other lung diseases in elderly patients with lung cancer, it will contribute to the development of a mobile application for identification of radiation pneumonitis, which can be used by the patients at home. Trial registration: clinicaltrials.gov (NCT06480734; URL: https://clinicaltrials.gov/show/NCT06480734); protocol version 1.2, registered on 27th of June, 2024.
Empowering Alzheimer's Caregivers with Conversational AI: A Novel Approach for Enhanced Communication and Personalized Support
Zaman, Kimia Tuz , Li, Juan , Xie, Bo, Hasan, Wordh Ul , Wang, Xin , Xie, Bo , Tao, Cui

No container title available | August 10, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4690070/v1 Get It

Abstract Alzheimer's disease and related dementias (ADRD) significantly impact patients and their caregivers, causing emotional stress, lack of training, and financial strain for the latter. Addressing the need for effective support, this research developed and validated ADQueryAid, a conversational AI system designed to empower ADRD caregivers. Built on a Large Language Model (LLM) and enriched with authoritative ADRD information through a knowledge graph, ADQueryAid uses Retrieval Augmented Generation (RAG) techniques to retrieve relevant information from both structured and unstructured data sources. Prompt engineering and conversation policies ensure the delivery of informative, empathetic, and personalized responses. Evaluated via a Blind Within-Subjects Design study with 20 ADRD caregivers interacting with both ADQueryAid and a baseline model (ChatGPT 3.5) in fictional caregiving scenarios, the system's usability was assessed using the Chatbot Usability Questionnaire (CUQ). Results showed ADQueryAid significantly outperformed the baseline model across all CUQ metrics, offering more contextually relevant information, accurate guidance, and emotional support, which enhanced the caregiving experience. This study highlights the potential of AI to support ADRD caregivers by providing personalized assistance, with future research focusing on expanding the knowledge base, refining conversational strategies, and exploring the long-term impact on caregiver well-being and patient outcomes.
Evening Exercise Does Not Affect Sleep Health: A Systematic Review and Meta-Analysis
Tokavanich, Nithi , Keawkanha, Ponthakorn, Sowalertrat, Walit , Joensahakij, Setthawut , Cheungpasitporn, Wisit , Cheungpasitporn, Wisit , Siranart, Noppachai , Pajareya, Patavee , Prasitlumkum, Narut , Navaravong, Leenhapong , Chokesuwattanaskul, Ronpichai

No container title available | August 10, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4583679/v1 Get It

Abstract Background: The relationships between exercise timing and health outcomes including anthropometric indices, metabolic markers, and sleep health have not been clearly established. To gain better insights, we performed the meta-analysis to determine the effects of morning versus evening exercise on various health outcomes. Methods: We collected studies from MEDLINE, EMBASE, and Cochrane databases from inception to March 2023 to perform a meta-analysis. Exercise is defined as performing activity at least moderate intensity. For the outcomes of interest, the mean differences (MD) were employed using a random-effects model, the generic inverse variance method of DerSimonian and Laird. Results: A total of 716 patients were analyzed from 14 studies including randomized controlled trial and observational studies. We found no significant associations between exercise timing and several health-related parameters. Specifically, the data showed no notable differences in body weight (MD: -0.12 kg [95% CI −0.81 to 0.58]) and BMI (MD: -0.07 kg/m2 [95% CI −0.46 to 0.32]) when comparing morning and evening exercise sessions. Similarly, sleep latency was not significantly affected by exercise timing (MD: -2.24 minutes [95% CI −5.83 to 1.35]). Furthermore, changes in metabolic biomarkers, including LDL (MD: -6.64 mg/dL [95% CI −20.08 to 6.79]) and HDL (MD: 0.09 mg/dL [95% CI 0 to 0.17]), were not significantly associated with the timing of exercise. Conclusion: This meta-analysis found no significant relationship between exercise timing and health outcomes including anthropometric indices, metabolic markers, and sleep health. While considered as hypothesis generating, timing of exercise should equally prune patients’ health outcomes.
In Pursuit of Polka Dots
Hayes, Charlotte, Hayes, Charlotte

New England Journal of Medicine | August 10, 2024 | Volume: 391 | Issue: 7 | Pages: 582-583

10.1056/nejmp2404101 | PMID 39132948 Get It